These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 22429365)

  • 1. DAOA variants on diagnosis and response to treatment in patients with major depressive disorder and bipolar disorder.
    Chiesa A; Pae CU; Porcelli S; Han C; Lee SJ; Patkar AA; Park MH; Jun TY; Serretti A
    J Int Med Res; 2012; 40(1):258-65. PubMed ID: 22429365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Case-control association study of 14 variants of CREB1, CREBBP and CREM on diagnosis and treatment outcome in major depressive disorder and bipolar disorder.
    Crisafulli C; Shim DS; Andrisano C; Pae CU; Chiesa A; Han C; Patkar AA; Lee SJ; Serretti A; De Ronchi D
    Psychiatry Res; 2012 Jun; 198(1):39-46. PubMed ID: 22386572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Impact of a Single Nucleotide Polymorphism in SIGMAR1 on Depressive Symptoms in Major Depressive Disorder and Bipolar Disorder.
    Mandelli L; Wang SM; Han C; Lee SJ; Patkar AA; Masand PS; Pae CU; Serretti A
    Adv Ther; 2017 Mar; 34(3):713-724. PubMed ID: 28144920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DAOA variants and schizophrenia: influence on diagnosis and treatment outcomes.
    Chiesa A; Pae CU; Porcelli S; Han C; Lee SJ; Patkar AA; Park MH; Serretti A
    Int J Psychiatry Clin Pract; 2011 Nov; 15(4):303-10. PubMed ID: 22122005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of TPH2 variants on diagnosis and response to treatment in patients with major depression, bipolar disorder and schizophrenia.
    Serretti A; Chiesa A; Porcelli S; Han C; Patkar AA; Lee SJ; Park MH; Pae CU
    Psychiatry Res; 2011 Aug; 189(1):26-32. PubMed ID: 21396719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cognitive manic symptoms in bipolar disorder associated with polymorphisms in the DAOA and COMT genes.
    Hukic DS; Frisén L; Backlund L; Lavebratt C; Landén M; Träskman-Bendz L; Edman G; Schalling M; Ösby U
    PLoS One; 2013; 8(7):e67450. PubMed ID: 23861766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of BDNF variants on diagnosis and response to treatment in patients with major depression, bipolar disorder and schizophrenia.
    Pae CU; Chiesa A; Porcelli S; Han C; Patkar AA; Lee SJ; Park MH; Serretti A; De Ronchi D
    Neuropsychobiology; 2012; 65(1):1-11. PubMed ID: 22094229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The DAOA/G30 locus and affective disorders: haplotype based association study in a polydiagnostic approach.
    Gawlik M; Wehner I; Mende M; Jung S; Pfuhlmann B; Knapp M; Stöber G
    BMC Psychiatry; 2010 Jul; 10():59. PubMed ID: 20667145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genotypic association of the DAOA gene with resting-state brain activity in major depression.
    Chen J; Xu Y; Zhang J; Liu Z; Xu C; Zhang K; Shen Y; Xu Q
    Mol Neurobiol; 2012 Oct; 46(2):361-73. PubMed ID: 22851402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between DAOA gene polymorphisms and the risk of schizophrenia, bipolar disorder and depressive disorder.
    Tan J; Lin Y; Su L; Yan Y; Chen Q; Jiang H; Wei Q; Gu L
    Prog Neuropsychopharmacol Biol Psychiatry; 2014 Jun; 51():89-98. PubMed ID: 24447945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of catechol-O-methyltransferase SNPs and haplotypes on treatment response phenotypes in major depressive disorder: a case-control association study.
    Kocabas NA; Faghel C; Barreto M; Kasper S; Linotte S; Mendlewicz J; Noro M; Oswald P; Souery D; Zohar J; Massat I
    Int Clin Psychopharmacol; 2010 Jul; 25(4):218-27. PubMed ID: 20531207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Variation at the DAOA/G30 locus influences susceptibility to major mood episodes but not psychosis in schizophrenia and bipolar disorder.
    Williams NM; Green EK; Macgregor S; Dwyer S; Norton N; Williams H; Raybould R; Grozeva D; Hamshere M; Zammit S; Jones L; Cardno A; Kirov G; Jones I; O'Donovan MC; Owen MJ; Craddock N
    Arch Gen Psychiatry; 2006 Apr; 63(4):366-73. PubMed ID: 16585465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploratory genome-wide association analysis of response to ketamine and a polygenic analysis of response to scopolamine in depression.
    Guo W; Machado-Vieira R; Mathew S; Murrough JW; Charney DS; Grunebaum M; Oquendo MA; Kadriu B; Akula N; Henter I; Yuan P; Merikangas K; Drevets W; Furey M; Mann JJ; McMahon FJ; Zarate CA; Shugart YY
    Transl Psychiatry; 2018 Dec; 8(1):280. PubMed ID: 30552317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of DAO and G72(DAOA)/G30 genes with bipolar affective disorder.
    Prata D; Breen G; Osborne S; Munro J; St Clair D; Collier D
    Am J Med Genet B Neuropsychiatr Genet; 2008 Sep; 147B(6):914-7. PubMed ID: 18165970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of GRIA1, GRIA2 and GRIA4 polymorphisms on diagnosis and response to treatment in patients with major depressive disorder.
    Chiesa A; Crisafulli C; Porcelli S; Han C; Patkar AA; Lee SJ; Park MH; Jun TY; Serretti A; Pae CU
    Eur Arch Psychiatry Clin Neurosci; 2012 Jun; 262(4):305-11. PubMed ID: 22057216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GTP cyclohydrolase 1 gene haplotypes as predictors of SSRI response in Japanese patients with major depressive disorder.
    Kishi T; Ichinose H; Yoshimura R; Fukuo Y; Kitajima T; Inada T; Kunugi H; Kato T; Yoshikawa T; Ujike H; Musso GM; Umene-Nakano W; Nakamura J; Ozaki N; Iwata N
    J Affect Disord; 2012 Dec; 142(1-3):315-22. PubMed ID: 22770721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of purinergic receptor P2RX7 gene polymorphisms with depression symptoms.
    Vereczkei A; Abdul-Rahman O; Halmai Z; Nagy G; Szekely A; Somogyi A; Faludi G; Nemoda Z
    Prog Neuropsychopharmacol Biol Psychiatry; 2019 Jun; 92():207-216. PubMed ID: 30664971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psychosis and relapse in bipolar disorder are related to GRM3, DAOA, and GRIN2B genotype.
    Dalvie S; Horn N; Nossek C; van der Merwe L; Stein DJ; Ramesar R
    Afr J Psychiatry (Johannesbg); 2010 Sep; 13(4):297-301. PubMed ID: 20957330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Common and rare variants of DAOA in bipolar disorder.
    Maheshwari M; Shi J; Badner JA; Skol A; Willour VL; Muzny DM; Wheeler DA; Gerald FR; Detera-Wadleigh S; McMahon FJ; Potash JB; Gershon ES; Liu C; Gibbs RA
    Am J Med Genet B Neuropsychiatr Genet; 2009 Oct; 150B(7):960-6. PubMed ID: 19194963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DISC1-TSNAX and DAOA genes in major depression and citalopram efficacy.
    Arias B; Fabbri C; Serretti A; Drago A; Mitjans M; Gastó C; Catalán R; Fañanás L
    J Affect Disord; 2014 Oct; 168():91-7. PubMed ID: 25043320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.